Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J Lambers Heerspink, Hans-Henrik Parving, Dennis L Andress, George Bakris, Ricardo Correa-Rotter, Fan-Fan Hou, Dalane W Kitzman, Donald E Kohan, Hirofumi Makino, John J. V. McMurray, Joel Z Melnick, Michael G Miller, Pablo E Pergola, Vlado Perkovic, Sheldon W Tobe, Tingting Yi, Melissa Wigderson, Dick de Zeeuw, David J Webb

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalThe Lancet
Volume393
Issue number10184
DOIs
Publication statusPublished - 11 May 2019

Cite this